Insider: LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER - HALOZYME THERAPEUTICS, INC.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 173,856 | 0 | 173,856 |
| Value | $12,860,128.32 | $0.00 | $12,860,128.32 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 02/27/2025 | DDS | 1,597 | Direct | COM | $58.25 | $93,028.44 | 173,856 |
| 02/27/2025 | DDS | 100 | Direct | COM | $58.74 | $5,874.00 | 173,756 |
| 02/26/2025 | DDS | 9,400 | Direct | COM | $58.09 | $546,055.40 | 176,053 |
| 02/26/2025 | DDS | 600 | Direct | COM | $58.65 | $35,188.80 | 175,453 |
| 02/25/2025 | DDS | 9,300 | Direct | COM | $58.01 | $539,465.10 | 186,153 |
| 02/25/2025 | DDS | 700 | Direct | COM | $58.67 | $41,069.00 | 185,453 |
| 10/16/2024 | DDS | 10,000 | Direct | COM | $53.26 | $532,590.00 | 173,756 |
| 10/15/2024 | DDS | 9,923 | Direct | COM | $53.74 | $533,291.79 | 173,833 |
| 10/15/2024 | DDS | 77 | Direct | COM | $54.25 | $4,176.87 | 173,756 |
| 09/18/2024 | DDS | 7,963 | Direct | COM | $61.89 | $492,838.03 | 175,793 |
| 09/18/2024 | DDS | 2,037 | Direct | COM | $62.58 | $127,477.50 | 173,756 |
| 09/17/2024 | DDS | 10,000 | Direct | COM | $62.88 | $628,780.00 | 173,756 |
| 08/21/2024 | DDS | 100 | Direct | COM | $62.34 | $6,234.00 | 168,176 |
| 08/21/2024 | DDS | 9,900 | Direct | COM | $61.74 | $611,235.90 | 168,276 |
| 08/20/2024 | DDS | 10,000 | Direct | COM | $61.06 | $610,550.00 | 168,176 |
| 06/18/2024 | DDS | 10,000 | Direct | COM | $49.43 | $494,260.00 | 168,176 |
| 05/22/2024 | DDS | 10,000 | Direct | COM | $45.38 | $453,840.00 | 168,176 |
| 05/21/2024 | DDS | 10,000 | Direct | COM | $45.16 | $451,640.00 | 168,176 |
| 04/17/2024 | DDS | 10,000 | Direct | COM | $38.49 | $384,890.00 | 168,176 |
| 04/16/2024 | DDS | 10,000 | Direct | COM | $38.35 | $383,500.00 | 168,176 |
| 03/13/2024 | DDS | 10,000 | Direct | COM | $42.27 | $422,730.00 | 156,558 |
| 03/12/2024 | DDS | 10,000 | Direct | COM | $41.64 | $416,370.00 | 156,558 |
| 02/28/2024 | DDS | 2,529 | Direct | COM | $39.56 | $100,044.71 | 156,558 |
| 02/28/2024 | DDS | 7,471 | Direct | COM | $39.54 | $295,418.28 | 156,558 |
| 02/27/2024 | DDS | 10,000 | Direct | COM | $39.95 | $399,460.00 | 159,087 |
| 1 2 3 Next Last You are at page 1 of 3 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research